Buscador de publicacions

Publicacions

  • Marina Caballero Bellón, Santa-María López V, Marti-Sanchez L, Martorell-Sampol L, Salinas D, Hinojosa J, Becerra MV, Pavon-Mengual M, Morales-La Madrid A, Cruz-Martínez O, Muchart-Lopez J and Salvador-Hernandez H.

    Very early-onset symptomatic CNS haemangioblastoma in Von Hippel-Lindau disease.

    JOURNAL OF MEDICAL GENETICS . 62(6): 409-412.

    [doi:10.1136/jmg-2024-110477]

  • Salvador, L, del Valle, J, Dorca, E, Chong, AS, Chong, AL, Valenzuela, JC, Munté, E, Rioja, C, Marti-Sanchez L, Salinas, M, Darder, E, Fabian, MR, Brunet, J, Salvador-Hernandez H, Lázaro, C and Rivera, B.

    DICER1 in pediatric and adult cancer predisposition populations: Prevalence, phenotypes, and mosaicism

    GENETICS IN MEDICINE . 27(5): .

    [doi:10.1016/j.gim.2025.101385]

  • Balaguer-Lluna L, Gene-Olaciregui N, Aschero MR, Resa-Parés C, Paco-Mercader S, Cuadrado-Vilanova M, Burgeño-Sandoval V, Baulenas-Farrés M, Monterrubio C, Manzanares-Quintela A, Rodriguez E, Lavarino C, Mora J and Carcaboso AM.

    Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas.

    JOURNAL OF NEURO-ONCOLOGY . 172(3): 599-611.

    [doi:10.1007/s11060-025-04954-w]

  • Zhang D, Sánchez-Espino LF, Ivars M, Pope E, Nopper AJ, Arkin LM, Tollefson MM, Lavarino C, Muldowney M, Gene-Olaciregui N, Paco-Mercader S, Drolet BA and Baselga E.

    Phenotypic Spectrum of GNA11 R183C Mosaicism.

    PEDIATRIC DERMATOLOGY . 42(3): 475-480.

    [doi:10.1111/pde.15802]

  • Ortega-Bertran S, Fernández-Rodríguez J, Magallón-Lorenz M, Zhang X, Creus-Bachiller E, Diazgranados AP, Uriarte-Arrazola I, Mazuelas H, Blanco I, Valverde C, Carrió M, Villanueva A, De Raedt T, Romagosa C, Gel B, Salvador-Hernandez H, Ferrer M, Lázaro C and Serra E.

    Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models

    CLINICAL CANCER RESEARCH . 31(5): 907-920.

    [doi:10.1158/1078-0432.CCR-24-2807]

  • Cristina Larrosa Espinosa, Simao-Rafael M, Salvador-Marcos N, Muñoz JP, Lavarino C, Chantada G and Mora J.

    Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy

    Frontiers in pediatrics . 12: 1509645-1509645.

    [doi:10.3389/fped.2024.1509645]

  • Sentís I, Melero JL, Cebrià A, Grzelak M, Soto M, Michel A, Rovira Q, Rodriguez-Hernandez CJ, Caratù G, Urpi A, Sauvage C, Mendizabal-Sasieta A, Maspero D, Lavarino C, Pascual-Reguant A, Castañeda-Heredia A, Muñoz Perez JP, Mora J, Harari A, Nieto JC, Avgustinova A and Heyn H.

    Spatio-temporal T cell tracking for personalized TCR-T designs in childhood cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology . : .

    [doi:10.1016/j.annonc.2025.05.530]

  • Planas-Roman S, Salvador-Marcos N, Lavarino C, Zuccarino F, Pereda D, Muñoz JP and Aurensanz E.

    Hamartoma of mature cardiac myocytes presenting as a polypoid epicardial tumor in the interatrial groove and with gene fusions by copy number anomalies of chromosome 7

    CARDIOVASCULAR PATHOLOGY . 73: 107660-107660. Nº de cites: 2

    [doi:10.1016/j.carpath.2024.107660]

  • Chirica M, Jurmeister P, Teichmann D, Koch A, Perez E, Schmid S, Simon M, Driever PH, Bodden C, van Tilburg CM, Hardin EC, Lavarino C, Hench J, Scheie D, Cryan J, Vicha A, Buttarelli FR, Michiels A, Haberler C, Barahona P, Tops BBJ, Jacques T, Stokland T, Witt O, Jones DTW and Capper D.

    DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centres

    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY . 50(5): .

    [doi:10.1111/nan.13010]

  • Ottenhoff MJ, Mous SE, Castricum J, Rietman AB, Oostenbrink R, van der Vaart T, Tulen JHM, Parra-Checa A, Ramos F, Legius E, Moll HA, Elgersma Y and de Wit MY.

    Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo-controlled trial

    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY . : 537-549. Nº de cites: 3

    [doi:10.1111/dmcn.16094]